INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
SEC FORM 4/Open-market purchaseVerified data

Spears Kelvin bought NUTX

Director · Nutex Health Inc. · Common Stock

Side
BUY
Value
$945
Shares
10
Price
$94.46
Executed
Mar 17, 2026
Disclosed
Mar 18, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 17 executedMar 18, 2026 disclosed

NUTX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
34/ 100 · ELEVATED
Methodology →
  • Transaction type+20 / 20

    Open-market purchase

  • Relative size+1 / 25

    $945 reported value · 0.0% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · NUTX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    29
    SJ
    Saunders Scott JDirector
    NUTXNutex Health Inc.
    Open-market sale
    		SELL$43K
    203 sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    12
    SK
    Spears KelvinDirector
    NUTXNutex Health Inc.
    Other acquisition or disposition
    		J—
    2,519 sh
    		Jun 4, 2026Jun 4, 2026
    traded Jun 4, 2026
    		+0dSEC FORM 4

    Evidence

    12
    VT
    Vo Thomas T.Director, Chief Executive Officer
    NUTXNutex Health Inc.
    Other acquisition or disposition
    		J—
    75.7K sh
    		May 28, 2026May 29, 2026
    traded May 28, 2026
    		+1dSEC FORM 4

    Evidence

    21
    GY
    Grenas Cheryl YvonneDirector
    NUTXNutex Health Inc.
    Grant or award
    		A—
    823 sh
    		Apr 23, 2026Apr 24, 2026
    traded Apr 23, 2026
    		+1dSEC FORM 4

    Evidence

    21
    SJ
    Saunders Scott JDirector
    NUTXNutex Health Inc.
    Grant or award
    		A—
    823 sh
    		Apr 23, 2026Apr 24, 2026
    traded Apr 23, 2026
    		+1dSEC FORM 4

    Evidence

    21
    RL
    Reed Michael LeeDirector
    NUTXNutex Health Inc.
    Grant or award
    		A—
    823 sh
    		Apr 23, 2026Apr 24, 2026
    traded Apr 23, 2026
    		+1dSEC FORM 4

    Evidence

    27
    VT
    Vo Thomas T.Director, Chief Executive Officer
    NUTXNutex Health Inc.
    Option exercise
    		M—
    4,841 sh
    		Mar 10, 2026Apr 10, 2026
    traded Mar 10, 2026
    		+31dSEC FORM 4

    Evidence

    16
    VT
    Vo Thomas T.Director, Chief Executive Officer
    NUTXNutex Health Inc.
    Other acquisition or disposition
    		J—
    184.1K sh
    		Apr 9, 2026Apr 10, 2026
    traded Apr 9, 2026
    		+1dSEC FORM 4

    Evidence

    19
    BS
    Bamburg Wesley ShaneChief Operating Officer
    NUTXNutex Health Inc.
    Option exercise
    		M—
    2,411 sh
    		Mar 11, 2026Mar 24, 2026
    traded Mar 11, 2026
    		+13dSEC FORM 4

    Evidence

    31
    SK
    Spears KelvinDirector
    NUTXNutex Health Inc.
    Option exercise
    		M—
    116 sh
    		Mar 10, 2026Mar 18, 2026
    traded Mar 10, 2026
    		+8dSEC FORM 4

    Evidence

    34
    MW
    Montgomery Pamela W.Chief Legal Officer-Healthcare
    NUTXNutex Health Inc.
    Open-market purchase
    		BUY$7,021
    79 sh
    		Mar 13, 2026Mar 16, 2026
    traded Mar 13, 2026
    		+3dSEC FORM 4

    Evidence

    27
    MW
    Montgomery Pamela W.Chief Legal Officer-Healthcare
    NUTXNutex Health Inc.
    Option exercise
    		M—
    1,523 sh
    		Mar 10, 2026Mar 16, 2026
    traded Mar 10, 2026
    		+6dSEC FORM 4

    Evidence

    13
    BC
    Bates Jon ChristianChief Financial Officer
    NUTXNutex Health Inc.
    Option exercise
    		M—
    2,667 sh
    		Mar 10, 2026Mar 11, 2026
    traded Mar 10, 2026
    		+1dSEC FORM 4

    Evidence

    9
    SK
    Spears KelvinDirector
    NUTXNutex Health Inc.
    Option exercise
    		M—
    183 sh
    		Mar 10, 2026Mar 11, 2026
    traded Mar 10, 2026
    		+1dSEC FORM 4

    Evidence

    9
    SK
    Spears KelvinDirector
    NUTXNutex Health Inc.
    Tax withholding
    		F$7,070
    82 sh
    		Mar 10, 2026Mar 11, 2026
    traded Mar 10, 2026
    		+1dSEC FORM 4

    Evidence

    17
    SK
    Spears KelvinDirector
    NUTXNutex Health Inc.
    Option exercise
    		M—
    116 sh
    		Mar 10, 2026Mar 11, 2026
    traded Mar 10, 2026
    		+1dSEC FORM 4

    Evidence

    13
    BC
    Bates Jon ChristianChief Financial Officer
    NUTXNutex Health Inc.
    Option exercise
    		M—
    1,694 sh
    		Mar 11, 2026Mar 11, 2026
    traded Mar 11, 2026
    		+0dSEC FORM 4

    Evidence

    24
    GY
    Grenas Cheryl YvonneDirector
    NUTXNutex Health Inc.
    Grant or award
    		A—
    603 sh
    		Jul 14, 2025Feb 9, 2026
    traded Jul 14, 2025
    		+210dSEC FORM 4

    Evidence

    24
    SJ
    Saunders Scott JDirector
    NUTXNutex Health Inc.
    Grant or award
    		A—
    603 sh
    		Jul 14, 2025Feb 9, 2026
    traded Jul 14, 2025
    		+210dSEC FORM 4

    Evidence

    24
    RL
    Reed Michael LeeDirector
    NUTXNutex Health Inc.
    Grant or award
    		A—
    603 sh
    		Jul 14, 2025Feb 9, 2026
    traded Jul 14, 2025
    		+210dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002018803-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Mar 17, 2026
    Published
    Mar 18, 2026
    Ingested by INSIDER
    Nov 5, 04:11 UTC
    Last re-read
    Nov 5, 04:11 UTC

    Extracted facts

    Filer
    Spears Kelvin
    Role
    Director
    Transaction
    Open-market purchaseAs filed: “P”
    Asset
    Nutex Health Inc.
    Ticker
    NUTX
    Shares
    10
    Price per share
    $94.46
    Value
    $945
    Execution date (reported)
    Mar 17, 2026
    Owned after transaction
    32.1K shares
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 10
    • Price: $94.46

    = $945

    What this establishes

    Spears Kelvin filed this Form 4 reporting a open-market purchase of NUTX on Mar 17, 2026. It became public on Mar 18, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Spears Kelvincik:0002018803
    Issuer
    Nutex Health Inc.cik:0001479681

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.